Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma | Reinhard Dummer, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà , John M Kirkwood , chiarion sileni vanna, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon , Caroline Robert , Laurent Mortier, Jacob Schachter, Thierry Lesimple, Ruth Plummer , Kohinoor Dasgupta , Eduard Gasal , Monique Tan, Georgina V Long, Dirk Schadendorf | NEW ENGLAND JOURNAL OF MEDICINE | 74.699 |
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties | Panciera Tito, Citron Anna, Di Biagio Daniele, Battilana Giusy, Gandin Alessandro, Giulitti Stefano, Forcato Mattia, Bicciato Silvio, Panzetta Valeria, Fusco Sabato, Azzolin Luca, Totaro Antonio, Dei Tos Angelo Paolo, Fassan Matteo, Vindigni Vincenzo, Bassetto Franco, Rosato Antonio, Brusatin Giovanna, Cordenonsi Michelangelo, Piccolo Stefano | NATURE MATERIALS | 38.663 |
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial > | Reinhard Dummer, Jan C Brase, James Garrett, Catarina D Campbell, Eduard Gasal, Matthew Squires, Daniel Gusenleitner , Mario Santinami , Victoria Atkinson , Mario Mandalà, chiarion sileni vanna, Keith Flaherty , James Larkin, Caroline Robert , Richard Kefford, John M Kirkwood , Axel Hauschild , Dirk Schadendorf , Georgina V Long | LANCET ONCOLOGY | 33.752 |
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial | Ascierto Paolo A., Del Vecchio Michele, Mandalá Mario, Gogas Helen, Arance Ana M., Dalle Stephane, Cowey C. Lance, Schenker Michael, Grob Jean Jacques, chiarion sileni vanna, Márquez-Rodas Iván, Butler Marcus O., Maio Michele, Middleton Mark R., de la Cruz-Merino Luis, Arenberger Petr, Atkinson Victoria, Hill Andrew, Fecher Leslie A., Millward Michael, Khushalani Nikhil I., Queirolo Paola, Lobo Maurice, de Pril Veerle, Loffredo John, Larkin James, Weber Jeffrey | LANCET ONCOLOGY | 33.752 |
Five-year outcomes with nivolumab in patients with wild-type BRAF advanced melanoma | Robert Caroline, Long Georgina V., Brady Benjamin, Dutriaux Caroline, Di Giacomo Anna Maria, Mortier Laurent, Rutkowski Piotr, Hassel Jessica C., McNeil Catriona M., Kalinka Ewa Anna, Lebbé Céleste, Charles Julie, Hernberg Micaela M., Savage Kerry J., chiarion sileni vanna, Mihalcioiu Catalin, Mauch Cornelia, Arance Ana, Cognetti Francesco, Ny Lars, Schmidt Henrik, Schadendorf Dirk, Gogas Helen, Zoco Jesús, Re Sandra, Ascierto Paolo A., Atkinson Victoria | JOURNAL OF CLINICAL ONCOLOGY | 32.956 |
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations | Lambertini Matteo, Ameye Lieveke, Hamy Anne Sophie, Zingarello Anna, Poorvu Philip D., Carrasco Estela, Grinshpun Albert, Han Sileny, Rousset-Jablonski Christine, Ferrari Alberta, Paluch-Shimon Shani, Cortesi Laura, Senechal Claire, Miolo Gianmaria, Pogoda Katarzyna, Pérez-Fidalgo Jose Alejandro, De Marchis Laura, Ponzone Riccardo, Livraghi Luca, Estevez-Diz Maria Del Pilar, Villarreal-Garza Cynthia, Dieci Maria Vittoria, Clatot Florian, Berlière Martine, Graffeo Rossella, Teixeira Luis, Córdoba Octavi, Sonnenblick Amir, Luna Pais Helena, Ignatiadis Michail, Paesmans Marianne, Partridge Ann H., Caron Olivier, Saule Claire, Del Mastro Lucia, Peccatori Fedro A., Azim Hatem A. | JOURNAL OF CLINICAL ONCOLOGY | 32.956 |
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome | Capaci Valeria, Bascetta Lorenzo, Fantuz Marco, Beznoussenko Galina V., Sommaggio Roberta, Cancila Valeria, Bisso Andrea, Campaner Elena, Mironov Alexander A., Wi¿niewski Jacek R., Ulloa Severino Luisa, Scaini Denis, Bossi Fleur, Lees Jodi, Alon Noa, Brunga Ledia, Malkin David, Piazza Silvano, Collavin Licio, Rosato Antonio, Bicciato Silvio, Tripodo Claudio, Mantovani Fiamma, Del Sal Giannino | NATURE COMMUNICATIONS | 12.121 |
Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma | Ascierto Paolo Antonio, Del Vecchio Michelle, Mackiewicz Andrzej, Robert Caroline, chiarion sileni vanna, Arance Ana, Lebbé Céleste, Svane Inge Marie, Mcneil Catriona, Rutkowski Piotr, Loquai Carmen, Mortier Laurent, Hamid Omid, Bastholt Lars, Dreno Brigitte, Schadendorf Dirk, Garbe Claus, Nyakas Marta, Grob Jean Jacques, Thomas Luc, Liszkay Gabriella, Smylie Michael, Hoeller Christoph, Ferraresi Virginia, Grange Florent, Gutzmer Ralf, Pikiel Joanna, Hosein Fareeda, Simsek Burcin, Maio Michele | JOURNAL OF IMMUNOTHERAPY OF CANCER | 10.252 |
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors | Dieci Maria Vittoria, Miglietta Federica, Griguolo Gaia, Guarneri Valentina | CANCER TREATMENT REVIEWS | 8.885 |
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy | Dieci Maria Vittoria, Tsvetkova Vassilena, Griguolo Gaia, Miglietta Federica, Tasca Giulia, Giorgi Carlo Alberto, Cumerlato Enrico, Massa Davide, Lo Mele Marcello, Orvieto Enrico, Guarneri Valentina, Conte Pierfranco | EUROPEAN JOURNAL OF CANCER | 7.275 |
Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules | Pinton Laura, Sara Magri, Elena Masetto, Marina Vettore, Ilaria Schibuola, Ingangi Vincenzo, Marigo Ilaria, Kevin Matha, Jean-Pierre Benoit, Alessandro Della Puppa, Vincenzo Bronte, Giovanna Lollo, Mandruzzato Susanna | JOURNAL OF NANOBIOTECHNOLOGY | 6.518 |
Reactive Oxygen Species and Antitumor Immunity-From Surveillance to Evasion | KOTSAFTI ANDROMACHI, Scarpa Marco, Castagliuolo Ignazio, Scarpa Melania | CANCERS | 6.126 |
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice | International Immuno-Oncology Biomarker Working Group Gruppo, Gonzalez-Ericsson Paula I, Stovgaard Elisabeth S, Sua Luz F, Reisenbichler Emily, Kos Zuzana, Carter Jodi M, Michiels Stefan, Le Quesne John, Nielsen Torsten O, Laenkholm Anne-Vibeke, Fox Stephen B, Adam Julien, Bartlett John Ms, Rimm David L, Quinn Cecily, Peeters Dieter, Dieci Maria Vittoria, Vincent-Salomon Anne, Cree Ian, Hida Akira I, Balko Justin M, Haynes Harry R, Frahm Isabel, Acosta-Haab Gabriela, Balancin Marcelo, Bellolio Enrique, Yang Wentao, Kirtani Pawan, Sugie Tomoharu, Ehinger Anna, Castaneda Carlos A, Kok Marleen, McArthur Heather, Siziopikou Kalliopi, Badve Sunil, Fineberg Susan, Gown Allen, Viale Giuseppe, Schnitt Stuart J, Pruneri Giancarlo, Penault-Llorca Frederique, Hewitt Stephen, Thompson E Aubrey, Allison Kimberly H, Symmans William F, Bellizzi Andrew M, Brogi Edi, Moore David A, Larsimont Denis, Dillon Deborah A. | JOURNAL OF PATHOLOGY | 6.021 |
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | Kos Zuzana, Roblin Elvire, Kim Rim S, Michiels Stefan, Gallas Brandon D, Chen Weijie, van de Vijver Koen K, Goel Shom, Adams Sylvia, Demaria Sandra, Viale Giuseppe, Nielsen Torsten O, Badve Sunil S, Symmans W Fraser, Sotiriou Christos, Rimm David L, Hewitt Stephen, Denkert Carsten, Loibl Sibylle, Luen Stephen J, Bartlett John M S, Savas Peter, Pruneri Giancarlo, Dillon Deborah A, Cheang Maggie Chon U, Tutt Andrew, Hall Jacqueline A, Kok Marleen, Horlings Hugo M, Madabhushi Anant, van der Laak Jeroen, Ciompi Francesco, Laenkholm Anne-Vibeke, Bellolio Enrique, Gruosso Tina, Fox Stephen B, Araya Juan Carlos, Floris Giuseppe, Hude¿ek Jan, Voorwerk Leonie, Beck Andrew H, Kerner Jen, Larsimont Denis, Declercq Sabine, Van den Eynden Gert, Pusztai Lajos, Ehinger Anna, Yang Wentao, Curigliano Giuseppe, Dieci Maria Vittoria, International Immuno-Oncology Biomarker Working Group Gruppo | NPJ BREAST CANCER | 6 |
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells | Sommaggio Roberta, Cappuzzello Elisa, Dalla Pietà Anna, Tosi Anna, Palmerini Pierangela, Carpanese Debora, Nicolè Lorenzo, Rosato Antonio | ONCOIMMUNOLOGY | 5.869 |